MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol

Despite progress in the treatment of head and neck squamous cell carcinoma (HNSCC) in recent decades, including new surgical techniques, radiotherapy advances and chemotherapy schedules, the prognosis for the affected patients has not improved at the same pace, and still, most HNSCC patients are dia...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Arantes, Lidia Maria Rebolho Batista, Laus, Ana Carolina, Melendez, Matias Eliseo, de Carvalho, Ana Carolina, Sorroche, Bruna Pereira, De Marchi, Pedro Rafael Martins, Evangelista, Adriane Feijó, Scapulatempo-Neto, Cristovam, de Souza Viana, Luciano, Carvalho, André Lopes
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354780/
https://ncbi.nlm.nih.gov/pubmed/28039483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14253
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia